Similar articles

• Can a better patient phenotyping predict the efficacy of tiotropium in asthmatic adolescents?

  Liccardi G, Calzetta L, Salzillo A, Piccolo A, Pane G, Rogliani P. Liccardi G, et al. Expert Opin Pharmacother. 2017 Jun;18(8):833-835. doi: 10.1080/14656566.2017.1317980. Epub 2017 Apr 28. Expert Opin Pharmacother. 2017. PMID: 28399659 No abstract available.
• Tiotropium in asthmatic adolescents symptomatic despite inhaled corticosteroids: a randomised dose-ranging study.

  Vogelberg C, Engel M, Moroni-Zentgraf P, Leonaviciute-Klimantaviciene M, Sigmund R, Downie J, Nething K, Vevere V, Vandewalker M. Vogelberg C, et al. Respir Med. 2014 Sep;108(9):1268-76. doi: 10.1016/j.rmed.2014.06.011. Epub 2014 Jul 17. Respir Med. 2014. PMID: 25081651 Clinical Trial.
• Clinical improvement by tiotropium plus olodaterol.

  Tamura T, Kagohashi K, Satoh H. Tamura T, et al. Respir Med. 2017 Apr;125:104. doi: 10.1016/j.rmed.2016.03.010. Epub 2016 Mar 18. Respir Med. 2017. PMID: 27017081 No abstract available.
• [Tiotropium--the "surgical" drug].

  Mihălţan F. Mihălţan F. Pneumologia. 2004 Oct-Dec;53(4):189-92. Pneumologia. 2004. PMID: 16106727 Review. Romanian. No abstract available.
• Why choose tiotropium for my patient? A comprehensive review of actions and outcomes versus other bronchodilators.

  Halpin DM, Kaplan AG, Russell RK. Halpin DM, et al. Respir Med. 2017 Jul;128:28-41. doi: 10.1016/j.rmed.2017.04.008. Epub 2017 Apr 18. Respir Med. 2017. PMID: 28610667 Review.